What is Celletech?
Celletech, Ltd. operates as a specialized provider of homeopathic and homeotherapeutic products, maintaining a robust market presence through well-known brands such as Hylands Cell Salts and Boericke & Tafel. The company distinguishes itself by prioritizing GMO-free formulations, catering to a growing demographic of health-conscious consumers seeking natural, non-pharmaceutical alternatives for family care and everyday wellness. By bridging the gap between traditional homeopathic practices and modern consumer expectations, Celletech has solidified its role as a key player in the alternative medicine landscape, emphasizing both product integrity and customer-centric support channels.
How much funding has Celletech raised?
Celletech has raised a total of $38K across 1 funding round:
Debt
$38K
Debt (2021): $38K with participation from PPP
Key Investors in Celletech
PPP
Public-Private Partnership
What's next for Celletech?
Moving into its next phase of growth, Celletech is expected to leverage this capital to optimize its supply chain and expand its distribution footprint. Given the current Series B/C stage, the strategic focus will likely shift toward scaling production capabilities and enhancing brand visibility to capture a larger share of the wellness market. The infusion of capital provides the firm with the financial runway to explore new product development and potentially integrate advanced digital health platforms to better serve its client base, ensuring long-term sustainability in an increasingly crowded natural health ecosystem.
See full Celletech company page
